logo
Plus   Neg
Share
Email

JinkoSolar Slips To Loss In Q4; Sees Q1 Revenue Below View - Quick Facts

JinkoSolar Holding Co., Ltd. (JKS) reported that its net loss attributable to the company's ordinary shareholders was RMB377.0 million or US$57.8 million for the fourth quarter of 2020, compared to net income of RMB369.5 million in the fourth quarter of 2019. Loss per ADS was RMB14.40 or US$2.21, compared to earnings per ADS of RMB6.68 last year.

In Friday pre-market trade, JKS was trading at $35.31 down $3.55 or 9.14 percent.

Non-GAAP earnings per ADS were RMB0.74 or US$0.11 compared to RMB 9.74 in the prior year.

Total revenues in the fourth quarter of 2020 were RMB9.42 billion or US$1.44 billion, a decrease of 1.1% from RMB9.53 billion in the fourth quarter of 2019.

Analysts polled by Thomson Reuters expect the company to report earnings of $0.37 per share and revenues of $1.38 billion for the fourth-quarter. Analysts' estimates typically exclude special items.

For the first quarter of 2021, the company expects total solar module shipments to be in the range of 4.5 GW to 5.0 GW, and total revenue of US$1.18 billion to US$1.30 billion. Analysts expect revenues of $1.31 billion for the first-quarter.

For full year 2021, the company estimates total shipments, including solar cell and wafer, to be in the range of 25 GW to 30 GW.

JinkoSolar expects its annual mono wafer, solar cell and solar module production capacity to reach 33 GW, 27 GW, including 800 MW N-type cells, and 37 GW, respectively, by the end of 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fast-food giant McDonald's said it will be raising hourly wages for more than 36,500 hardworking employees at McDonald's-owned restaurants by an average of 10 percent to make it among the industry-leading pay and benefits package. These increases, which have already begun, will be rolled out over the next several months. Biogen Inc. (BIIB) Friday said its XIRIUS study of cotoretigene toliparvovec failed to meet its primary endpoint in Phase 2/3 in patients with X-linked retinitis pigmentosa or XLRP. The company further noted that the study obtained positive trends in other pre-specified clinically relevant endpoints,... General Mills Inc. (GIS) agreed to buy Tyson Foods' (TSN) pet treats business for $1.2 billion in cash, the companies said in a statement on Friday. The transaction includes the Nudges, Top Chews and True Chews brands. General Mills will also acquire a manufacturing facility in Independence, Iowa.
Follow RTT